Patent EP0088642A2 successfully refreshed from Google Patents.
Patent EP0020147A1 successfully refreshed from Google Patents.
← Back to Patent Explorer
EP0020147A1 Expired / Lapsed EP ⏱️ 0.0 years remaining

A DNA transfer vector for human pre-growth hormone, a microorganism transformed thereby, and a method of cloning therefor

Assignee: University of California
•
Filing: 1980-05-29
•
Granted: —
•
Expires: 2000-05-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A DNA having a base sequence coding for human pregrowth hormone has been cloned, and novel recombinant DNA transfer vectors containing said cloned DNA have been constructed. Novel microorganisms transformed by said recombinant transfer vectors have been obtained. Certain of said transformed microorganisms have demonstrated capability to express the cloned DNA, by synthesizing a protein comprising human pre-growth hormone.

Inventors

  • 👤 John Darling Baxter
  • 👤 Howard Michael Goodman
  • 👤 Joseph Augustin Martial
  • 👤 Robert Alexander Hallewell

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-27 10:06
CPC Classifications
C; C12; C12N; C12N15/00; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/61; C12N1/00; C12N1/20; C12N1/205; C12P; C12P21/00; C12P21/02; C07K2319/00; C07K2319/01; C07K2319/02; C07K2319/70; C07K2319/74; C07K2319/75; C12R; C12R2001/00; C12R2001/01; C12R2001/185; C12R2001/19

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 13 words
A DNA transfer vector comprising a deoxynucleotide sequence coding for human pre-growth hormone.
Claim 2
Dependent Claim 13 words
A DNA transfer vector comprising a deoxynucleotide sequence coding for human pre-growth hormone.
Claim 3
Dependent Claim 30 words
The transfer vector of claim 1 wherein the deoxynucleotide sequence coding for human pre-growth hormone is derived from messenger RNA isolated from the pituitary gland cells of an individual human.
Claim 4
Dependent Claim 10 words
A microorganism transformed by the transfer vector of claim 1.
Claim 5
Dependent Claim 218 words
A DNA transfer vector comprising a deoxynucleotide sequence coding for human pre-growth hormone comprising: A is deoxyadenyl, G is deoxyguanyl, C is deoxycytosyl, T is thymidyl, J is A or G; K is T or C; L is A, TC or G; M is A, C or T; Xn is T or C, if Y n is A or G, and C if Y n is C or T; Y n is A, G, C, or T, if X is C, and A or G if X is T; W n is C or A, if Z n is G or A, and C if Z n is C or T; Z is A, G, C or T, if W n is C, and A or G if W n is A; QR n is TC, if S n is A, G, C or T, and AG if S n is T or C; S n is A, G , C or T, if QR n is TC, and T or C if QR n is AG and subscript numerals, n, refer to the position in the amino acid sequence of human growth hormone, to which each triplet in the nucleotide sequence corresponds, according to the genetic code, the amino acid positions being numbered from the amino end.
Claim 6
Dependent Claim 218 words
A DNA transfer vector comprising a deoxynucleotide sequence coding for human pre-growth hormone comprising: A is deoxyadenyl, G is deoxyguanyl, C is deoxycytosyl, T is thymidyl, J is A or G; K is T or C; L is A, TC or G; M is A, C or T; Xn is T or C, if Y n is A or G, and C if Y n is C or T; Y n is A, G, C, or T, if X is C, and A or G if X is T; W n is C or A, if Z n is G or A, and C if Z n is C or T; Z is A, G, C or T, if W n is C, and A or G if W n is A; QR n is TC, if S n is A, G, C or T, and AG if S n is T or C; S n is A, G , C or T, if QR n is TC, and T or C if QR n is AG and subscript numerals, n, refer to the position in the amino acid sequence of human growth hormone, to which each triplet in the nucleotide sequence corresponds, according to the genetic code, the amino acid positions being numbered from the amino end.
Claim 7
Dependent Claim 10 words
A microorganism transformed by the transfer vector of claim 4.
Claim 8
Dependent Claim 3 words
The plasmid pBR322/HGH800.
Claim 9
Dependent Claim 3 words
The plasmid pBR322/HGH800.
Claim 10
Dependent Claim 9 words
A microorganism transformed by the plasmid of claim 6.
Claim 11
Dependent Claim 3 words
The plasmid ptrpED50-HGH.
Claim 12
Dependent Claim 3 words
The plasmid ptrpED50-HGH.
Claim 13
Dependent Claim 9 words
A microorganism transformed by the plasmid of claim 8.
Claim 14
Dependent Claim 9 words
A microorganism as in claim 9 comprising Escherichia coli.
Claim 15
Dependent Claim 27 words
A chimeric protein comprising the amino acid sequence of human pre-growth hormone as its C-terminal sequence, and a portion of a procaryotic protein as its N-terminal sequence.
Claim 16
Dependent Claim 27 words
A chimeric protein comprising the amino acid sequence of human pre-growth hormone as its C-terminal sequence, and a portion of a procaryotic protein as its N-terminal sequence.
Claim 17
Dependent Claim 20 words
The protein of claim 11 wherein the procaryotic portion is coded by part of the trpD gene of Escherichia coli.
Claim 18
Independent Claim 283 words
A method for cloning a deoxynucleotide sequence coding for human pre-growth hormone from pituitary gland tissue of an individual human, comprising the steps of a) extracting mRNA coding for human pre-growth hormone from an individual human pituitary gland, b) separating the mRNA substantially free of protein, DNA and other RNA, c) synthesizing a single-stranded cDNA having a nucleotide sequence complementary to that of the mRNA, in a series of procedures including incubation with an enzyme, extraction to remove protein from the reaction mixture, alcohol precipitation, and alkaline hydrolysis, all of said procedures being carried out in the same reaction tube, in the absence of added carrier DNA, d) purifying the single-stranded cDNA by chromatography wherein those fractions containing the single-stranded DNA are located by a radioassay which does not consume the reaction product, e) synthesizing double-stranded cDNA having one strand with a nucleotide sequence corresponding to that of the mRNA, in a series of procedures including incubation with an enzyme, and extraction to remove protein, said procedures being carried out in a single reaction tube in the absence of added carrier DNA, f) purifying the double-stranded cDNA by chromatography as in step d), g) further treating the double-stranded cDNA with enzyme, essentially as described in steps e) and f) to provide end groups suitable for inserting the cDNA into a DNA transfer vector, h) inserting the double-stranded cDNA into a DNA transfer vector, thereby forming a recombinant transfer vector, i) transforming a microorganism with the recombinant transfer vector, and j) selecting a microorgamism strain derived from a single transformed cell transformed by a recombinant transfer vector containing cDNA coding for human pre-growth hormone, thereby cloning a deoxynucleotide sequence coding for human pre-growth hormone.
Claim 19
Independent Claim 283 words
A method for cloning a deoxynucleotide sequence coding for human pre-growth hormone from pituitary gland tissue of an individual human, comprising the steps of a) extracting mRNA coding for human pre-growth hormone from an individual human pituitary gland, b) separating the mRNA substantially free of protein, DNA and other RNA, c) synthesizing a single-stranded cDNA having a nucleotide sequence complementary to that of the mRNA, in a series of procedures including incubation with an enzyme, extraction to remove protein from the reaction mixture, alcohol precipitation, and alkaline hydrolysis, all of said procedures being carried out in the same reaction tube, in the absence of added carrier DNA, d) purifying the single-stranded cDNA by chromatography wherein those fractions containing the single-stranded DNA are located by a radioassay which does not consume the reaction product, e) synthesizing double-stranded cDNA having one strand with a nucleotide sequence corresponding to that of the mRNA, in a series of procedures including incubation with an enzyme, and extraction to remove protein, said procedures being carried out in a single reaction tube in the absence of added carrier DNA, f) purifying the double-stranded cDNA by chromatography as in step d), g) further treating the double-stranded cDNA with enzyme, essentially as described in steps e) and f) to provide end groups suitable for inserting the cDNA into a DNA transfer vector, h) inserting the double-stranded cDNA into a DNA transfer vector, thereby forming a recombinant transfer vector, i) transforming a microorganism with the recombinant transfer vector, and j) selecting a microorgamism strain derived from a single transformed cell transformed by a recombinant transfer vector containing cDNA coding for human pre-growth hormone, thereby cloning a deoxynucleotide sequence coding for human pre-growth hormone.

References Cited (Backward Citations)

LU79714A1 Cited
DE2825595A1 Cited
EP0001929A2 Cited
GB2031434A Cited

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag